Cargando…

Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System

With our increasing appreciation of the true complexity of diseases and pathophysiologies, it is clear that this knowledge needs to inform the future development of pharmacotherapeutics. For many disorders, the disease mechanism itself is a complex process spanning multiple signaling networks, tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssens, Jonathan, Etienne, Harmonie, Idriss, Sherif, Azmi, Abdelkrim, Martin, Bronwen, Maudsley, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150252/ https://www.ncbi.nlm.nih.gov/pubmed/25225492 http://dx.doi.org/10.3389/fendo.2014.00142

Ejemplares similares

BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality
por: Siddiqui, Sana, et al.
Publicado: (2013)

G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence
por: Santos-Otte, Paula, et al.
Publicado: (2019)

Genomic deletion of GIT2 induces a premature age-related thymic dysfunction and systemic immune system disruption
por: Siddiqui, Sana, et al.
Publicado: (2017)

G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response Processes
por: Leysen, Hanne, et al.
Publicado: (2018)

The RXFP3 receptor is functionally associated with cellular responses to oxidative stress and DNA damage
por: van Gastel, Jaana, et al.
Publicado: (2019)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
por: Puglisi, Soraya, et al.
Publicado: (2021)

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021)

GIT2 Acts as a Systems-Level Coordinator of Neurometabolic Activity and Pathophysiological Aging
por: Martin, Bronwen, et al.
Publicado: (2016)

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
por: Du, Haiyang, et al.
Publicado: (2022)

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
por: Wang, Jing-Yue, et al.
Publicado: (2023)

Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison
por: Jung, Han Na, et al.
Publicado: (2022)

Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
por: Tanday, Neil, et al.
Publicado: (2021)

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
por: Baldassano, Sara, et al.
Publicado: (2019)

Allosteric and Biased G Protein-Coupled Receptor Signaling Regulation: Potentials for New Therapeutics
por: Khoury, Etienne, et al.
Publicado: (2014)

An emerging role for adenosine and its receptors in bone homeostasis
por: Ham, Jack, et al.
Publicado: (2012)

Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
por: Liu, Lulu, et al.
Publicado: (2022)

Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
por: Cignarelli, Angelo, et al.
Publicado: (2022)

Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
por: Hu, Weiting, et al.
Publicado: (2022)

Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
por: Gallwitz, Baptist
Publicado: (2022)

Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
por: Diz-Chaves, Yolanda, et al.
Publicado: (2022)

G Protein-Coupled Receptors in Osteoarthritis
por: Wang, Fanhua, et al.
Publicado: (2022)

Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations
por: Meier, Juris J., et al.
Publicado: (2021)

Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
por: Wei, Jinjing, et al.
Publicado: (2022)

LGR4, a G Protein-Coupled Receptor With a Systemic Role: From Development to Metabolic Regulation
por: Filipowska, Joanna, et al.
Publicado: (2022)

Central Role of the EGF Receptor in Neurometabolic Aging
por: Siddiqui, Sana, et al.
Publicado: (2012)

Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER
por: Gigoux, Véronique, et al.
Publicado: (2013)

The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice
por: Mansur, Sity Aishah, et al.
Publicado: (2019)

Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
por: Tsai, Chih-Yiu, et al.
Publicado: (2022)

Impact of GLP-1 receptor agonist versus omega-3 fatty acids supplement on obesity-induced alterations of mitochondrial respiration
por: Jansen, Kirsten M., et al.
Publicado: (2023)

Neuropeptide G Protein-Coupled Receptors as Oncotargets
por: Moody, Terry W., et al.
Publicado: (2018)

Kisspeptin/Kisspeptin Receptor System in the Ovary
por: Hu, Kai-Lun, et al.
Publicado: (2018)

Higher TNF-α, IGF-1, and Leptin Levels are Found in Tasters than Non-Tasters
por: Wang, Rui, et al.
Publicado: (2014)

Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
por: Wei, Jinjing, et al.
Publicado: (2022)

G protein-coupled receptors: Role in metabolic disorders
por: Barella, Luiz F., et al.
Publicado: (2022)

Allosteric modulation of G protein-coupled receptor signaling
por: Shen, Siyuan, et al.
Publicado: (2023)

GRK5 – A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders
por: Hendrickx, Jhana O., et al.
Publicado: (2018)

Interactions between β-arrestin proteins and the cytoskeletal system, and their relevance to neurodegenerative disorders
por: Szénási, Tibor, et al.
Publicado: (2023)

GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?
por: Brunton, S
Publicado: (2014)

The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88e6ha1g09d2hcbgd3at8lttjd